Moody's affirms 'A2' rating on WakeMed Health's bonds

Alyssa Rege -

Moody's Investors Service affirmed the "Aa2" rating on Raleigh, N.C.-based WakeMed Health's bonds, affecting $400 million of rated debt.

The ratings affirmation is based on a number of factors, including the health system's solid market share as well as its strong operating performance in fiscal year 2016.

The outlook is stable, reflecting Moody's Investors Service's expectation the health system will maintain or improve its operating performance above FY 2016 levels.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.